Kezar Life Sciences, Inc. (KZR) by event type
KZR moves most on analyst downgrades — a median of +1.29% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the KZR overview →
How KZR reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 70 of 2,603 | 10 | +1.29% | 70% | +3.92% |
| Rating reiterations 928 of 3,522 | 31 | +0.08% | 52% | +0.14% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how KZR usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · KZR overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Apollo Medical Holdings, Inc. (AMEH) | 192 | +0.16% | 55% |
| Citius Pharmaceuticals, Inc. (CTXR) | 192 | -1.42% | 30% |
| TAKEDA PHARMA (TKPYY) | 192 | 0.00% | 47% |
| Arbutus Biopharma Corporation (ABUS) | 191 | +0.11% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.